Eosinophil peroxidase (EPX) is a major constituent of the large cytoplasmic granules of both human and mouse eosinophilic leukocytes. Human EPX deficiency is a rare, autosomal-recessive disorder limited to the eosinophil lineage. Our intent was to explore the impact of EPX gene deletion on eosinophil content, structure, and function. In response to repetitive intranasal challenge with a filtrate of the allergen, Alternaria alternata, we found significantly fewer eosinophils peripherally and in the respiratory tracts of EPX −/− mice compared to wild-type controls; furthermore, both the major population (Gr1 −/lo ) and the smaller population of Gr1 hi eosinophils from EPX −/− mice displayed lower median fluorescence intensities (MFIs) for Siglec F. Quantitative evaluation of transmission electron micrographs of lung eosinophils confirmed the relative reduction in granule outer matrix volume in cells from the EPX −/− mice, a finding analogous to that observed in human EPX deficiency. Despite the reduced size of the granule matrix, the cytokine content of eosinophils isolated from allergen-challenged EPX −/− and wild-type mice were largely comparable to one another, although the EPX −/− eosinophils contained reduced concentrations of IL-3.
INTRODUCTION
Eosinophils are immunomodulatory leukocytes with complex roles in health and disease that remain poorly understood. 1, 2 As but one example, eosinophils are recognized as primary inflammatory cells that are recruited to and activated in the respiratory tract as part of the pathophysiology of severe eosinophilic asthma. 3 However, from an evolutionary perspective, eosinophils would no longer exist within living vertebrate species if their sole function was to promote human and mouse eosinophils (reviewed in Acharya and Ackerman 12 ).
Archer and Hirsch 13 were among the first to characterize peroxidase activity in eosinophil granules; purification schemes for EPX from guinea pig and horse eosinophils followed shortly thereafter. 14, 15 Human and mouse EPX polypeptides were isolated, followed by cDNA and genomic sequences. 16, 17 EPX is highly conserved, with 90% amino acid sequence homology between human and mouse orthologs; both are also homologous to their respective neutrophil myeloperoxidases. Mature EPX consists of two-polypeptides (55 kDa heavy and 15 kDa light chain) linked by disulfide bonds; active EPX generates hypohalous acids from ambient hydrogen peroxide generated by eosinophil NADPH oxidase. 18, 19 Among other functions, Klebanoff and colleagues 20, 21 found that EPX displayed prominent antibacterial activity against gram-negative bacteria in experiments carried out ex vivo in the presence of exogenous hydrogen peroxide and halide ions.
In 1968, Presentey 22 No specific clinical findings were attributed to EPX deficiency and transmission of this trait was determined to be autosomal recessive. 23 Hereditary EPX deficiency was later reported in several families undergoing routine blood testing in Northern Italy; Romano and colleagues 24 identified a G to A transition within the coding sequences (exon 7) from one cohort that resulted in conversion of Arg 286 to His.
Affected individuals generated immunoreactive EPX that was spectroscopically abnormal and did not react appropriately with cytochemical dyes. Nakagawa and colleagues 25 described another cohort in which a G to A transition (exon 11) resulted in a conversion of Asp 648 to Asn, a mutation that could alter the three-dimensional conformation and catalytic capacity of the EPX molecule.
The EPX gene-deleted (EPX −/− ) mouse strain generated and characterized by Denzler and colleagues 26 represents a model of profound EPX deficiency. These mice generate no EPX due to disruption of the coding sequence at exons 6, 7, and 8. Analogous to the human clinical syndrome, eosinophils from EPX −/− mice appear normal at the light microscopic level and granules are intact, although granule size was visually reduced secondary to loss of volume in the granule matrix. Of interest, this observation is in profound contrast to that seen in mice devoid of the granule core protein MBP-1, in which granule biosynthesis is highly irregular and eosinophils are nearly unrecognizable at the light microscopic level. 27 Mice devoid of both EPX and MBP-1 are unable to generate eosinophils at all, 28 results suggesting that EPX deficiency alone may have a larger impact on eosinophil development and homeostasis than has been previously considered.
Our intent in this study was to explore the overall impact of EPX gene deletion on eosinophil contents, structure, and function.
Earlier work, including ours, suggested that EPX gene deletion had no impact on eosinophil recruitment to the lungs and airways using standard intraperitoneal adjuvant-mediated sensitization and challenge strategies. [26] [27] [28] [29] In these studies, the relevant antigens, either ovalbumin 26 or extract of Aspergillus fumigatus (Percopo et al. 29 ;
family Trichomaceae) were combined with an aluminum-containing adjuvant and administered as an intraperitoneal sensitization agent prior to secondary respiratory challenges. Although highly effective at promoting eosinophil recruitment to the lungs and airways, the alum adjuvant-enhanced Th2 response 30 may mask subtle differences between the wild-type and the gene-deleted mouse strain.
Here, we examine eosinophils from EPX −/− mice utilizing a more physiologic, purely intranasal challenge strategy (i.e., no adjuvants or intraperitoneal sensitization) featuring antigens in a filtrate from Alternaria alternata (family Pleosporaceae), a saprophytic fungus and environmental aeroallergen that has been clinically associated with the development of allergic asthma. 31 We have also explored the interactions allergen-challenged wild-type and EPX −/− mice with Haemophilus influenzae a gram-negative pathogen and that has been implicated in airway disease. [32] [33] [34] 
MATERIALS AND METHODS

Mice
Wild-type C57BL/6 mice (7-10 weeks old) were from Charles River Laboratories (Frederick, MD, USA). Eosinophil-deficient ΔdblGATA mice 35 on the C57BL/6 background are maintained in the 14BS vivarium on campus. EPX −/− mice on the C57BL/6 background originally described by Denzler and colleagues 26 
Challenge with alternaria alternata and evaluation of cells and cytokines in the airways
Mice under isoflurane anesthesia were inoculated intranasally via repetitive challenge with a reconstituted filtrate of A. alternata (Stallergenes-Greer, Lenoir, NC, USA; stock 10 mg/mL, diluted to 50 g/mouse in 50 L PBS with 0.1% BSA) on days 0, 3, and 6 as shown in Fig. 1 . At day 10, mice were sacrificed and subjected to bronchoalveolar lavage (BAL) with PBS with 0.1% BSA.
Cytospins were prepared and stained with modified Giemsa intranasally with a filtrate of the fungus, Alternaria alternata (Aa) on days 0, 3, and 6 followed by evaluation at day 10 as indicated. B. Modified Giemsa-stained cytospin preparations of eosinophils from the airways of wild-type (WT) and C. EPX −/− mice subjected to repetitive challenge with Aa as per Fig. 1A . D.-G. Transmission electron micrographs (original magnification, 49,000×) of eosinophils from WT and EPX −/− mice as described in B. and C., respectively; red-filled arrowheads denote granule matrix, red-outlined arrowheads denote the internal granule core in panels D. and F. H. Relative area; ratio of area of granule core/area of whole granule as determined using ImageJ 1.49v; **P < 0.02 Mann-Whitney U-test
Generation of bone marrow-derived eosinophils
Bone marrow-derived eosinophils (bmEos) were prepared from unselected progenitors from both wild-type and EPX −/− mice using the method previously described 36 with minor changes as follows. Briefly, bone marrow progenitors were flushed from the tibiae and femurs of mice with sterile RPMI; red blood cells were lysed and remaining cells were suspended at a concentration of 10 6 /mL in RPMI with 20% fetal calf serum, 25 mM HEPES, 100 IU/mL and 10 g/mL PenStrep, 2 mM glutamine, nonessential amino acids, 1 mM sodium pyruvate, 50 M beta-mercaptoethanol, 100 ng /mL recombinant murine (rm) stem cell factor (SCF), and rmFlt3-Ligand (Flt3L). On day 4, culture medium was replaced and included no SCF or FLt3-L but contained 10 ng/mL IL-5. Half of the media was replaced with fresh medium with 10 ng/mL IL-5 on days 6, 8, 10, 12, 14, 16, and 18; all nonadherent cells were moved to new flasks on days 8, 12, and 16. Cells were collected for analysis on day 20. In a recent study 37 we utilized bmEos from C57BL/6 mice from day 20 cultures which were effective at phagocytosing bacteria; viability of bmEos derived from C57BL/6 progenitors at day 20 in culture is >90% as shown in Supplemental Fig. 1 .
Flow cytometry, FACS, and evaluation of eosinophil contents
For routine flow cytometry, single cell suspensions were prepared from whole lung tissue of mice as previously described 29 ; upon thawing, Relative cytokine levels (from wild-type vs. EPX −/− mice) were determined using 300 g total protein (5.3 × 10 6 eosinophils) from each sample to probe a Cytokine profiler (ARY006; R&D Systems) as per manufacturer's instructions. Relative expression was evaluated by scanning on a (Licor Odyssey CLX, Lincoln, NE, USA). Scans were analyzed using Image Studio Ver 4.0 Software. Absolute levels of specific cytokines of interest were determined by Quantikine and DuoSet ELISA assays (R&D Systems).
Transmission electron microscopy and image evaluation
Eosinophils were isolated from mouse lung tissue by FACS as described 
Splenocyte isolation and challenge with PMA and ionomycin
Spleens were isolated from wild-type and EPX −/− mice challenged via intraperitoneal inoculation with antigen, either 50 g ovalbumin (Sigma) or 20 g A. fumigatus extract (Hollister-Stier, Spokane, Washington, USA) complexed with Imject Alum (Pierce). Splenocytes were generated from spleens minced in HBSS with 1% FBS and 10 mM HEPES and then passed through a 100 micron cell strainer. Splenocytes were pulled into a 10 ml syringe and passed through a 21-gauge needle, followed by centrifugation at 300 × g for 5 min. Cell pellet was resuspended in 1 ml of HBSS, 1% FBS, 10 mM HEPES, and red blood cells were lysed with distilled water followed by 10× PBS. Cells were enumerated using trypan blue dye exclusion and resuspended at 5 × 10 6 cells per ml of RPMI 1640 plus 10% FBS (Atlanta Biologicals, Flowery Branch, GA), Penicillin 10 units/mL and Streptomycin 10 g/mL (Life Technologies) and challenged with combined phorbol 12-myristate 13-acetate; (PMA; Sigma) at 20 ng/mL) and ionomycin (Sigma) at 1 g/mL for 3 h. IL-3 released into the supernatants was evaluated by ELISA using the Quantikine R&D kits as per manufacturer's instructions.
Culture, quantification, and in vivo challenge with Haemophilus influenzae
The nontypeable Haemophilus influenzae (NTHi) reference strain NCTC 4560 was obtained from American Type Culture Collection (Manassas, VA, USA; Cat. No. 19418). Colonies from frozen stocks maintained at −80 • C were generated by streaking onto sBHI agar plates (Brain Heart Infusion agar with 1 mg / mL NAD (Sigma) and 10 g/mL hemin (MP Biomedicals, LLC, Santa Ana, CA, USA) after overnight growth at 37 • C at 5% CO 2 . 38 Bacteria were inoculated into 30 mL of sBHI broth with NAD and hemin as above and grown to an OD 600 of 0.45, determined experimentally to generate 2 × 10 9 colony forming units (CFU)/mL. Bacteria were collected by centrifugation (4100 × g) and resuspended at 10 7 / mL in PBS with 0.1% BSA. Wild-type and EPX −/− mice challenged with A. alternata on days 0, 3, and 6 as described above were subjected to further intranasal challenge on day 10 with 5 × 10 5 CFU H. influenzae in 50 L prepared as above. At t = 2 h, mice were sacrificed and BAL fluid was collected. CFUs per mL BAL fluid were determined after overnight growth on sBHI agar plates at 37 • C in 5% CO 2 as described above.
Statistical analysis
All quantitative findings were from replicate datasets. 
RESULTS AND DISCUSSION
In this study, wild-type and EPX −/− mice were challenged intranasally with a filtrate of Alternaria alternata (50 g per mouse) on days 0, 3, and 6 as shown in Fig. 1A . We and others 39, 40 have found that this protocol, which uses no adjuvant and no distinct sensitization phase, results in eosinophil recruitment to the lungs and airways of wild-type mice.
Morphologic characterization of eosinophils from allergen-challenged EPX −/− mice
As noted in earlier publications, eosinophils from antigen-challenged EPX −/− mice appear normal at the light microscopic level. 26, 29 Eosinophils from the airways of A. alternata-challenged EPX −/− mice stained with modified Giemsa have ring-shaped, polymorphic nuclei with red-staining, microgranular cytoplasm, and are visually indistinguishable from those from the airways of A. alternata-challenged wildtype mice (Fig. 1B and C) .
Electron micrographs of peritoneal eosinophils isolated from EPX −/− mice suggested that the granule matrix, the site of EPX localization, was reduced in volume, 26 analogous to what has been described for human eosinophil deficiency. 23, 24 Transmission electron micrographs of eosinophils from the lungs of wild-type and EPX −/− mice challenged with a filtrate from A. alternata culture as in Fig. 1A are shown in Fig. 1D -G. As indicated by the arrows in Fig. 1D and F, among the most prominent differences are the characteristics of the large cytoplasmic granules. In the eosinophils from wild-type mice ( Fig. 1D and E) , the granule in cross section maintains a substantial outer matrix surrounding the central core. By contrast, the granule matrix in eosinophils from EPX −/− strain includes only a narrow margin of outer matrix around the granule core ( Fig. 1F and G) .
We examined this observation quantitatively by measuring the area of granule core relative to the total granule area. We confirmed that, Eosinophils were isolated by FACS from whole lungs of wild-type and EPX −/− mice subjected to repetitive challenge with A. alternata as in Fig. 1A ; isolation strategy is as described in the Methods and as shown in Fig. 1 of reference 29 ; 5 mice per group, **P < 0.01 by one-way ANOVA. B. Immunoreactive IL-3 released from splenocytes isolated from wild-type and EPX −/-mice (5 × 10 6 cells / mL) with and without challenge with PMA/ionomycin, n = 4-5 mice per group, ns, not significant, **P < 0.01 one-way ANOVA in eosinophil granules from EPX −/− mice, the core represents a larger fraction of the total granule area than in wild-type mice (0.47 ± 0.13 vs.
0.27 ± 0.05, **P < 0.02), representing a significant difference between these strains (Fig. 1H ).
Biochemical characterization of eosinophils from allergen-challenged EPX −/− mice
In addition to EPX, eosinophils store numerous pre-formed cytokine mediators. These cytokines are mobilized in response to biochemical and inflammatory stimuli and contribute to their immunomodulatory potential. [41] [42] [43] Initial screening of the eosinophils isolated from the lungs of A. alternata-challenged wild-type and EPX −/− mice by cytokine profiling suggested that the contents of eosinophils from the two strains were largely comparable to one another (data not shown). As shown in Fig. 2A , lysates were prepared from eosinophils isolated by FACS, which were then evaluated by ELISA. This analysis revealed that eosinophils from the lungs of A. alternata-challenged EPX −/− mice and wild-type mice contained largely comparable levels of IL-1Ra/IF3, CXCL12, and IL-1 ; however, eosinophils from wild-type mice contained relatively more immunoreactive IL-3 than eosinophils isolated from the lungs of A. alternata-challenged EPX −/− mice (ratio 5.3 ± 2.2; **P < 0.01 [ Fig. 2A]) . No IFN-, GM-CSF, IL-13, or IL17 was detected in eosinophil lysates from either strain (data not shown).
As reported by Doyle and colleagues, 28 the EPX −/-mice used in this study were backcrossed to the C57BL/6 wild-type parent strain for >20 generations; this is a process designed to eliminate any unanticipated mutations in gene-deleted mouse strains. Taken further, we show that splenocytes isolated from EPX −/− and wild-type mice that were activated ex vivo are capable of synthesizing and releasing equivalent amounts of immunoreactive IL-3 (Fig. 2B ). As such, we found no evidence for overall instability or diminished capacity at the IL-3 locus.
To date, there are only a few published reports that profile the cytokine contents of mouse eosinophils in a systematic fashion, 29, 44 although there have been several studies of this nature performed on human eosinophils. 42, 45 As is clear from these studies, and the comparative analysis presented by Lee and colleagues, 44 the cytokine contents of human and mouse eosinophils are far from identical, although both do contain IL-3, 29, 46 as discussed further below. To the best of our knowledge, cytokine biosynthesis and trafficking has not been examined in any of the known human EPX deficiency cohorts. [22] [23] [24] [25] The results of this work suggest that this may be an interesting area for future exploration.
EPX −/− mice respond to A. alternata challenge with diminished numbers of eosinophils in the lungs and reduced expression of Siglec F
We examined eosinophils (CD45 + CD11c − MHCII − Gr1 −/lo SiglecF + ) in bone marrow, spleen, and lungs of wild-type and EPX −/− mice subjected to repetitive challenge with A. alternata as in Fig. 1A . As shown in Fig. 3A , significantly fewer eosinophils were detected in the bone marrow, lungs, and in the spleens of EPX −/− mice compared to wild-type controls. Furthermore, whereas median fluorescence intensity (MFI) for Siglec F, the glycan-binding, immunoglobulin-like lectin, and major marker for the eosinophil lineage in mice (reviewed in O'Sullivan et al. 47 ) is highest on eosinophils isolated from the lungs compared to those from bone marrow and spleen, it is significantly lower among lung eosinophils from EPX −/− mice compared to wild-type (Fig. 3B) . As described previously for wild-type mice, 29 a small subset of SiglecF + Gr1 hi eosinophils was also identified in the lungs of EPX −/− mice (Fig. 3C) ; this subset from lungs of A. alternata-challenged EPX −/− mice also displayed a reduced MFI for Siglec F compared to those from A. alternata-challenged wild-type controls (Fig. 3D) .
Although the full implications of these findings remain unclear, as noted above, IL-3 has been detected in human eosinophils, 46 contributes to normal eosinophil hematopoiesis and is a pro-survival factor. 48 Of note, Yamamoto and colleagues 49 have shown that human eosinophils can be sustained by autocrine release of the pro-survival cytokine, GM-CSF, although this has not been demonstrated directly Fig. 1A ; n = 4-5 mice per group, *P < 0.05, **P < 0.01. B. Siglec F expression (median fluorescence intensity, MFI) on eosinophils in A., n = 10 mice per group **P < 0.01 C. Siglec F + Gr hi eosinophils identified in lungs of wild-type and EPX −/− mice subjected to repetitive Aa-challenge as in Fig. 1A , n = 5 mice per group, ns, not significant. D. Siglec F expression (MFI) on eosinophils in C., n = 5 mice per group, **P < 0.01 for murine counterparts. Nonetheless, we consider the possibility that the reduced numbers of eosinophils detected in EPX −/− mice (see Fig. 3A ) may relate to diminished intracellular content of IL-3, a hypothesis that awaits further evaluation.
Siglec F is a cell surface glycoprotein and marker of committed eosinophils. 47 Allergen-challenged Siglec-F −/− mice feature increased eosinophil numbers in the airways, a result that suggests that eosinophil numbers may be modulated in vivo by physiologic apoptosis via ligand-receptor interactions. 50 Although an imperfect measure of receptor numbers, eosinophils in the lungs of EPX −/− mice display a reduced MFI for Siglec F; as such, it is unlikely that the reduced number of eosinophils in the lungs (Fig. 3A) relates to enhanced Siglec Fmediated apoptosis. Of interest, McMillan and colleagues 51 reported that Siglec-F-dependent regulation of eosinophil numbers in the lung was dependent on the distinct attributes of the experimental model used for study. As the aforementioned studies both utilized ovalbumin sensitization and challenge models, the role of Siglec F in modulating eosinophil apoptosis in vivo might merit further evaluation in models featuring mice challenged with A. alternata.
We also examined expression of maturation markers; subpopulations of SiglecF + Gr1 −/lo eosinophils from the airways of wild-type and EPX −/-mice were also CCR3 + (33 ± 10%) or CD34 + (11 ± 7%); no CD125 was detected (Supplemental Fig. 2 ). CCR3 (CD193) is a receptor for the critical eosinophil chemoattractants, CCL11 and CCL24. 52 In a previous study, we found that anti-CCR3 detected only a fraction (26 ± 6%) of the Siglec F + cells in hypereosinophilic mouse bone marrow 53 ; the results presented here suggest that the same may be true for CD11c − Siglec F + eosinophils recruited to lungs of allergen-challenged mice. Of note, the anti-Gr1 antibody featured here detects the two distinct and cross-reacting cell surface antigens, Ly6G and Ly6C 54 ; we found previously that the SiglecF + Gr1 hi population is uniquely Ly6G + . 29 
Differential expression of the pattern recognition receptor, TLR4, on eosinophils from allergen-challenged wild-type and EPX −/− mice
Although pattern recognition receptors (PRRs) have been defined on human eosinophils, 55 comparatively less is known regarding their expression and function among populations of eosinophils in the mouse. 56 The role of PRRs in modulating eosinophil-mediated interactions with bacteria, including phagocytosis and generation of extracellular traps is likewise a subject that remains to be explored. 6, 10 The PRR, TLR4, is expressed widely among myeloid cells and responds to gram-negative bacterial LPS and endogenous proinflammatory ligands. 57 We find here that only a small fraction of eosinophils isolated from bone marrow, spleen or lungs of A. alternata-challenged mice are surface TLR4 + (see Supplemental Fig. 3 for gating strategy) .
F I G U R E 4
Pattern recognition receptors TLR4 on and NOD1 in eosinophils isolated from Aa-challenged wild-type and EPX −/− mice. A. TLR4 was detected on the surface of a fraction of eosinophils from bone marrow, spleen, and lung (fewer than 10% overall; see Supplemental Fig. 3 for gating strategy). A higher percentage of spleen and lung eosinophils from wild-type mice express TLR4 than do their EPX −/− counterparts; n = 5 mice per group, *P < 0.05. B. Highest MFI was detected among eosinophils isolated from the lung, although differential expression (wild-type vs. EPX −/− ) was detected in spleen only; n = 5 mice per group, *P < 0.05). C. TLR4 was detected on virtually all eosinophils in bone marrow, spleen, and lung after permeabilization; n = 4-5 mice per group, see Methods. D. NOD1 was detected in (permeabilized) eosinophils from bone marrow and spleen (the latter, on a larger percentage of EPX −/-than wild-type mice), and in smaller fraction of eosinophils recruited to the lung; n = 5 mice per group; *P< 0.05. E. Similar to findings documenting TLR4, the highest MFI was found among eosinophils in the lung; the MFI for NOD1 was greater among the wild-type eosinophils, n = 5 mice per group, *P < 0.05 Nonetheless, there are more TLR4 + eosinophils in the lungs and spleens of A. alternata-challenged wild-type than in EPX −/− mice (Fig. 4A) , although the MFI was higher among eosinophils isolated from the spleens of mice from the EPX −/− strain (Fig. 4B) . It is intriguing to consider these findings in light of those shown in Fig. 4C , in which we demonstrated that virtually all eosinophils contain intracellular stores of TLR4 (i.e., all are TLR4 + when the cells are fully permeabilized). Taken together, these findings suggest that the absence of EPX may have a broader impact on eosinophil cell structure and protein trafficking than is currently appreciated.
Although TLR-mediated signaling has been implicated in modulating allergic inflammation in mouse models, 58-61 expression of F I G U R E 5 A. alternata-challenged EPX −/− mice were just as effective as wild-type mice at clearing gram-negative Haemophilus influenzae from the airways. A. Basic protocol. Mice inoculated intranasally with a filtrate of the fungus, Alternaria alternata (Aa) on days 0, 3, and 6 as in Fig. 1A were challenged on day 10 with live H. influenzae (NTHi; 5 × 10 5 colony forming units (CFU) in logarithmic-phase growth in 50 L volume). CFU / mL in BAL fluid was determined at t = 2 h thereafter. B. Eosinophils detected in the airways (% of total leukocytes) of wild-type, EPX −/− , and ΔdblGATA eosinophil-deficient mice after Aa-challenge was determined as in Fig. 1A ; n = 3-4 mice per group, **P < 0.01, *P< 0.05. C. CFU / mL BAL fluid lung at t = 2 h after inoculation with 5 × 10 5 CFU NTHi as indicated in Fig. 5A ; n = 14-18 mice per group, bars indicate standard error of mean (SEM); *P< 0.05, ns, no significant difference (Fig. 5C ). Similar to our observations with TLR4 and Siglec F, MFI is highest among lung eosinophils; a somewhat lower MFI was observed among lung eosinophils from EPX −/− mice (Fig. 5D) . This pattern-a high fraction of NOD1 + eosinophils in the spleen and lower fraction of NOD1 + eosinophils in the lung-was also observed among eosinophils isolated from IL-5 transgenic mice (Supplemental Fig. 4 ). NOD1 receptors on spleen eosinophils are functional and respond in a dose-dependent fashion to biochemical ligand, iE-DAP (Kraemer and Rosenberg, unpublished data). TLR4 + and NOD1 + eosinophils in similar proportions were also detected on bone marrow-derived eosinophils 36 from both wild-type and EPX −/− mice (Supplemental Fig. 5 ).
NOD1 was detected in human peripheral blood eosinophils, and can be activated by the canonical ligand, iE-DAP to release the proinflammatory cytokine, CXCL8, and to up-regulate expression of CD11b, CD18, and ICAM-1. 64, 65 To the best of our knowledge, this is the first comprehensive evaluation of NOD1 expression in mouse eosinophils.
Apart from the differential expression observed between wild-type and EPX −/− mice, it is also interesting to note that the fraction of eosinophils that are NOD1 + differ depending on localization. This remarkable degree of eosinophil heterogeneity-for example, the frac- 21, 67 and has been implicated directly in specific nitrosylation and carbamoylation reactions in vivo. 68, 69 Furthermore, as shown here, EPX −/− mice display diminished recruitment of eosinophils to the lungs, and, of the eosinophils that are recruited, a smaller proportion are TLR4 + . Given these findings, we asked whether eosinophils, as a component of A. alternatamediated inflammation, might be effective in clearing gram-negative nontypeable Haemophilus influenzae (NTHi) from the airways, and whether EPX deficiency might have an impact on this activity; this was addressed via the protocol shown in Fig. 5A . As in whole lungs ( Fig. 2A) , fewer eosinophils were detected in the airways of EPX −/− mice on day 10 after challenge with A. alternata on days 0, 3, and 6, and none were detected in the airways of the eosinophil-deficient ΔdblGATA strain (Fig. 5B) . A. alternata-challenged mice of all three strains were inoculated intranasally with 5 × 10 5 colony forming units of NTHi and clearance from the airways was evaluated at 2 h thereafter. As shown in Fig. 5C , fewer colonies were detected overall (∼3-4-times) in the presence of eosinophilic inflammation (wild-type or EPX −/− vs. ΔdblGATA, *P < 0.05). However, clearance was no more effective from the airways of A. alternata-challenged wild-type mice than from their A. alternata-challenged EPX −/− counterparts (n.s., no significant difference). As such, the contributions of TLR4, NOD1, or for that matter, EPX, to bacterial clearance in this in vivo setting remain unclear.
In summary, we compared the responses of wild-type and EPX −/− mice to the physiologic aeroallergen, A. alternata, which elicits eosinophil recruitment to the lungs and airways following a brief period of repetitive challenge. We find that eosinophils are reduced in number both peripherally and in the lungs and airways in response 
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